Literature DB >> 11872089

Chemokines in allergic lung inflammation.

Clare Lloyd1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11872089      PMCID： PMC1782646          DOI： 10.1046/j.1365-2567.2002.01344.x

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  84 in total

Review 1.  Small molecule inhibitor of HIV-1 cell fusion blocks chemokine receptor-mediated function.

Authors:  O M Howard; T Korte; N I Tarasova; M Grimm; J A Turpin; W G Rice; C J Michejda; R Blumenthal; J J Oppenheim
Journal:  J Leukoc Biol       Date:  1998-07       Impact factor: 4.962

2.  A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus.

Authors:  T N Kledal; M M Rosenkilde; F Coulin; G Simmons; A H Johnsen; S Alouani; C A Power; H R Lüttichau; J Gerstoft; P R Clapham; I Clark-Lewis; T N Wells; T W Schwartz
Journal:  Science       Date:  1997-09-12       Impact factor: 47.728

Review 3.  Inhibition of interleukin-5 with a monoclonal antibody attenuates allergic inflammation.

Authors:  M Danzig; F Cuss
Journal:  Allergy       Date:  1997-08       Impact factor: 13.146

4.  Eotaxin expression and eosinophilic inflammation in asthma.

Authors:  S Mattoli; M A Stacey; G Sun; A Bellini; M Marini
Journal:  Biochem Biophys Res Commun       Date:  1997-07-18       Impact factor: 3.575

5.  Epithelial cells are a major cellular source of the chemokine eotaxin in the guinea pig lung.

Authors:  E B Cook; J L Stahl; C M Lilly; K J Haley; H Sanchez; A D Luster; F M Graziano; M E Rothenberg
Journal:  Allergy Asthma Proc       Date:  1998 Jan-Feb       Impact factor: 2.587

6.  The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells.

Authors:  A Zingoni; H Soto; J A Hedrick; A Stoppacciaro; C T Storlazzi; F Sinigaglia; D D'Ambrosio; A O'Garra; D Robinson; M Rocchi; A Santoni; A Zlotnik; M Napolitano
Journal:  J Immunol       Date:  1998-07-15       Impact factor: 5.422

7.  Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes.

Authors:  F Sallusto; D Lenig; C R Mackay; A Lanzavecchia
Journal:  J Exp Med       Date:  1998-03-16       Impact factor: 14.307

8.  Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo.

Authors:  A A Humbles; D M Conroy; S Marleau; S M Rankin; R T Palframan; A E Proudfoot; T N Wells; D Li; P K Jeffery; D A Griffiths-Johnson; T J Williams; P J Jose
Journal:  J Exp Med       Date:  1997-08-18       Impact factor: 14.307

9.  Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes.

Authors:  U Forssmann; M Uguccioni; P Loetscher; C A Dahinden; H Langen; M Thelen; M Baggiolini
Journal:  J Exp Med       Date:  1997-06-16       Impact factor: 14.307

10.  The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness.

Authors:  J A Gonzalo; C M Lloyd; D Wen; J P Albar; T N Wells; A Proudfoot; C Martinez-A; M Dorf; T Bjerke; A J Coyle; J C Gutierrez-Ramos
Journal:  J Exp Med       Date:  1998-07-06       Impact factor: 14.307
View more
  19 in total

1.  Two complementary, local excitation, global inhibition mechanisms acting in parallel can explain the chemoattractant-induced regulation of PI(3,4,5)P3 response in dictyostelium cells.

Authors:  Lan Ma; Chris Janetopoulos; Liu Yang; Peter N Devreotes; Pablo A Iglesias
Journal:  Biophys J       Date:  2004-10-01       Impact factor: 4.033

2.  Effects of steroid treatment on lung CC chemokines, apoptosis and transepithelial cell clearance during development and resolution of allergic airway inflammation.

Authors:  L Uller; C M Lloyd; K Rydell-Törmänen; C G A Persson; J S Erjefält
Journal:  Clin Exp Allergy       Date:  2006-01       Impact factor: 5.018

3.  Requirement for chemokine receptor 5 in the development of allergen-induced airway hyperresponsiveness and inflammation.

Authors:  Yasuko Fuchimoto; Arihiko Kanehiro; Nobuaki Miyahara; Hikari Koga; Genyo Ikeda; Koichi Waseda; Yasushi Tanimoto; Satoshi Ueha; Mikio Kataoka; Erwin W Gelfand; Mitsune Tanimoto
Journal:  Am J Respir Cell Mol Biol       Date:  2011-07-14       Impact factor: 6.914

4.  Multistrain genetic comparisons reveal CCR5 as a receptor involved in airway hyperresponsiveness.

Authors:  Julia K L Walker; Adriana Ahumada; Bryan Frank; Renee Gaspard; Katherine Berman; John Quackenbush; David A Schwartz
Journal:  Am J Respir Cell Mol Biol       Date:  2006-02-10       Impact factor: 6.914

5.  Genetic Deletion of β-Arrestin-2 and the Mitigation of Established Airway Hyperresponsiveness in a Murine Asthma Model.

Authors:  Minyong Chen; Akhil Hegde; Yeon Ho Choi; Barbara S Theriot; Richard T Premont; Wei Chen; Julia K L Walker
Journal:  Am J Respir Cell Mol Biol       Date:  2015-09       Impact factor: 6.914

6.  Early phase resolution of mucosal eosinophilic inflammation in allergic rhinitis.

Authors:  Lena Uller; Cecilia Ahlström Emanuelsson; Morgan Andersson; Jonas S Erjefält; Lennart Greiff; Carl G Persson
Journal:  Respir Res       Date:  2010-05-09

7.  Inhibition by new glucocorticoid antedrugs [16α, 17α-d] isoxazoline and [16α, 17α-d]-3'-hydroxy-iminoformyl isoxazoline derivatives of chemotaxis and CCL26, CCL11, IL-8, and RANTES secretion.

Authors:  Younes J Errahali; Leeshawn D Thomas; Thomas C S Keller; Henry J Lee
Journal:  J Interferon Cytokine Res       Date:  2013-05-16       Impact factor: 2.607

8.  Beta-arrestin-2 regulates the development of allergic asthma.

Authors:  Julia K L Walker; Alan M Fong; Barbara L Lawson; Jordan D Savov; Dhavalkumar D Patel; David A Schwartz; Robert J Lefkowitz
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

9.  Both hematopoietic-derived and non-hematopoietic-derived {beta}-arrestin-2 regulates murine allergic airway disease.

Authors:  John W Hollingsworth; Barbara S Theriot; Zhouwei Li; Barbara L Lawson; Mary Sunday; David A Schwartz; Julia K L Walker
Journal:  Am J Respir Cell Mol Biol       Date:  2009-10-05       Impact factor: 6.914

Review 10.  Chronic inflammation and asthma.

Authors:  Jenna R Murdoch; Clare M Lloyd
Journal:  Mutat Res       Date:  2009-09-19       Impact factor: 2.433
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.